We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+53.66%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
+$698M
(+93%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
28.92%
Top 10 Holdings %
Top 10 Hldgs %
21.33%
Holding
759
New
418
Increased
75
Reduced
55
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sea Limited
SE
|
+$13.2M |
| 2 |
Alibaba
BABA
|
+$6.77M |
| 3 |
United Parcel Service
UPS
|
+$4.23M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$4.19M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$4.03M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$16.2M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$4.48M |
| 3 |
Zoom
ZM
|
+$3.15M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.84M |
| 5 |
Lyft
LYFT
|
+$2.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 3.12% |
| 2 | Healthcare | 2.1% |
| 3 | Technology | 1.03% |
| 4 | Industrials | 0.75% |
| 5 | Financials | 0.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
PUT
Invesco Senior Loan ETF
BKLN
$6.96B
| $1.28M | 0.09% |
60,100
+10,100
| +20% | +$214K |
|
252
Citigroup
C
$213B
| $1.28M | 0.09% |
+25,000
| New | +$1.19M |
|
|
NBIS
253
PUT
Nebius Group N.V.
NBIS
$37.6B
| $1.25M | 0.09% |
25,000
-5,000
| -17% | -$200K |
|
254
Teva Pharmaceuticals
TEVA
$40.4B
| $1.23M | 0.09% |
+100,000
| New | +$1.13M |
|
|
255
PUT
Teva Pharmaceuticals
TEVA
$40.4B
| $1.23M | 0.09% |
+100,000
| New | +$1.13M |
|
256
STAAR Surgical
STAA
$1.19B
| $1.23M | 0.09% |
+20,000
| New | +$817K |
|
257
CALL
Boston Scientific
BSX
$68.4B
| $1.23M | 0.09% |
+35,000
| New | +$1.26M |
|
|
FISV
258
Fiserv Inc
FISV
$29.7B
| $1.22M | 0.08% |
+12,500
| New | +$1.26M |
|
|
RDS.B
259
CALL
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.22M | 0.08% |
40,000
| – | – |
|
260
CALL
Caesars Entertainment
CZR
$6.06B
| $1.2M | 0.08% |
30,000
-20,000
| -40% | -$554K |
|
261
CALL
Procter & Gamble
PG
$340B
| $1.2M | 0.08% |
+10,000
| New | +$1.17M |
|
262
PUT
Bank of America
BAC
$429B
| $1.19M | 0.08% |
+50,000
| New | +$1.18M |
|
|
ESPR
263
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.18M | 0.08% |
+23,000
| New | +$962K |
|
264
PUT
MGM Resorts International
MGM
$11.7B
| $1.18M | 0.08% |
70,000
-60,000
| -46% | -$969K |
|
265
Snap
SNAP
$7.96B
| $1.18M | 0.08% |
+50,000
| New | +$889K |
|
266
CALL
Kilroy Realty
KRC
$4.59B
| $1.17M | 0.08% |
+20,000
| New | +$1.21M |
|
267
CALL
Genesis Energy
GEL
$1.82B
| $1.17M | 0.08% |
+161,900
| New | +$1.1M |
|
|
ARNA
268
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.17M | 0.08% |
+18,500
| New | +$1.02M |
|
269
CALL
Dell
DELL
$239B
| $1.14M | 0.08% |
+41,038
| New | +$922K |
|
270
CALL
Datadog
DDOG
$94B
| $1.12M | 0.08% |
+12,900
| New | +$785K |
|
271
CALL
State Street SPDR S&P Biotech ETF
XBI
$10B
| $1.12M | 0.08% |
10,000
| – | – |
|
272
Walt Disney
DIS
$171B
| $1.11M | 0.08% |
10,000
-2,000
| -17% | -$221K |
|
273
CALL
Freeport-McMoran
FCX
$86.2B
| $1.1M | 0.08% |
+95,000
| New | +$871K |
|
274
PUT
Qualcomm
QCOM
$164B
| $1.09M | 0.08% |
+12,000
| New | +$962K |
|
275
CALL
Spotify
SPOT
$108B
| $1.08M | 0.08% |
+4,200
| New | +$720K |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q2 2020 Portfolio in Review
As of Q2 2020, SG3 Management held 759 positions worth $1.45B, up 93% from $748M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management deployed $418M of net new capital in Q2 2020, opening 418 new positions and adding to 75 existing holdings. Its largest new stake was Sea Limited: 183,000 shares worth $19.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 3.1% of assets, up from 2% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $1.21M trimmed.
- SG3 Management's largest Q2 2020 buy was Sea Limited: 183,000 shares worth $19.6M.
- SG3 Management added most to PENN Entertainment in Q2 2020, an estimated $2.45M increase.
- SG3 Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.21M.
- SG3 Management fully exited Tesla in Q2 2020, selling an estimated $16.2M.
- SG3 Management's ten largest holdings make up 21% of its $1.45B portfolio in Q2 2020.
- SG3 Management opened 418 new positions and closed 163 in Q2 2020.
- SG3 Management's portfolio value rose 93% quarter-over-quarter to $1.45B.
Based on SG3 Management's 13F filing for Q2 2020, filed 14 Aug 2020.